Comparing effect in the management of erectile dysfunction by using 2 sets of drugs of intracavernosal injection.
- Author:
Hong-Yan JIAN
1
;
Ji-Chang HAO
Author Information
- Publication Type:Clinical Trial
- MeSH: Adult; Erectile Dysfunction; drug therapy; Humans; Injections; Male; Middle Aged; Papaverine; administration & dosage; Phentolamine; administration & dosage; Pyrazines; administration & dosage
- From: National Journal of Andrology 2003;9(3):200-201
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVESTo supply clinical data for drug selextion in the treatment of erectile dysfunction through intracavernosal injection.
METHODSFifty-six ED patients were randomly classified into 2 groups and received phentolamine along with papaverine (for group 1) or phentolamine, papaverine and ligustrazin hydrochloride(for group 2).
RESULTSPatients in group 2 enjoyed a longer time of erection. More patients in group 2 succeeded in having enough erection time and hardness to complete sexual intercourse (P < 0.05).
CONCLUSIONSThe extrainjection of ligustrazin hydrochloride injection can help prolong erection duration and hardness and reduce tubercles that might occur in the corpus carvernosal. Therefore it is a safe and inexpensive drug in the intracarvernous injection treatment.
